Wednesday, October 11
14:05 - 14:35 BST
Fireside chat with Antoine Yver
Over several decades, Antoine Yver has worked on some of the most important cancer drugs currently available, most notably the big three at AstraZeneca: Tagrisso, Lynparza and Enhertu. His development work on Tagrisso stands out for its ultra-fast 2 year, 7 month long development period — from first dose to first approval. He and Editor John Carroll will talk about where the big cancer drugs of the future are coming from. And how long that takes.
Chairman of Development, Director & Member of the Board
Centessa Pharmaceuticals Ltd, SANOFI
Editor & Founder